Northern Trust Corp Caribou Biosciences, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 691,206 shares of CRBU stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

691,206

Previous 710,129 2.66%

Holding current value

$1.11 Million

Previous $1.16 Million 15.72%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.56 - $2.73 $29,519 - $51,659	-18,923 Reduced 2.66%	691,206 $1.35 Million
Q2 2024 Aug 14, 2024	SELL	$1.62 - $5.05 $39,100 - $121,886	-24,136 Reduced 3.29%	710,129 $1.16 Million
Q1 2024 May 14, 2024	SELL	$4.82 - $8.26 $111,327 - $190,781	-23,097 Reduced 3.05%	734,265 $3.77 Million
Q4 2023 Feb 13, 2024	BUY	$3.58 - $6.25 $251,305 - $438,731	70,197 Added 10.22%	757,362 $4.34 Million
Q3 2023 Nov 13, 2023	BUY	$4.08 - $8.14 $633,138 - $1.26 Million	155,181 Added 29.17%	687,165 $3.28 Million
Q2 2023 Aug 11, 2023	BUY	$4.04 - $5.47 $12,035 - $16,295	2,979 Added 0.56%	531,984 $2.26 Million
Q1 2023 May 15, 2023	SELL	$4.3 - $7.78 $23,572 - $42,649	-5,482 Reduced 1.03%	529,005 $2.81 Million
Q4 2022 Feb 13, 2023	BUY	$5.57 - $11.01 $63,102 - $124,732	11,329 Added 2.17%	534,487 $3.36 Million
Q3 2022 Nov 14, 2022	BUY	$5.34 - $12.79 $390,236 - $934,667	73,078 Added 16.24%	523,158 $5.52 Million
Q2 2022 Aug 12, 2022	BUY	$5.1 - $9.74 $236,180 - $451,059	46,310 Added 11.47%	450,080 $2.44 Million
Q1 2022 May 13, 2022	BUY	$8.42 - $15.32 $1.85 Million - $3.37 Million	219,683 Added 119.34%	403,770 $3.71 Million
Q4 2021 Feb 08, 2022	BUY	$14.59 - $23.26 $161,744 - $257,860	11,086 Added 6.41%	184,087 $2.78 Million
Q3 2021 Nov 15, 2021	BUY	$15.75 - $30.29 $2.72 Million - $5.24 Million	173,001 New	173,001 $4.13 Million

Others Institutions Holding CRBU

# of Institutions

135

Shares Held

52.6M

Call Options Held

148K

Put Options Held

70.7K

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $98M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Caribou Biosciences, Inc. Transaction History